The exosome diagnostic and therapeutic market in Europe is expected to grow from US$ 12,524.24 thousand in 2019 to US$ 1,04,694.72 thousand by 2027. This represents a CAGR of 31.7% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to greater precision and advantages over traditional methods of diagnosis and therapeutics, rise in research and development activities. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the Europe exosome diagnostic and therapeutic market during the forecast period.
The Germany has observed fast growth in the exosome diagnostic and therapeutic market within the past few years and is expected to lead the market in Europe during the forecast period. Currently, exosomes are rapidly gaining momentum in accessing therapeutic effects of stem cells. For instance, Cancer cases are rising in Germany, stressing on the need for advanced diagnostic tools. As per the Globocan, in 2018, nearly 608,742 cases of cancer were reported in the country. The country has one of the most advanced healthcare facilities and spends a significant amount on healthcare expenditure. Health insurance is mandatory in Germany and offered by two providers, the statutory health insurance (SHI) system and substitutive private health insurance (PHI). The advanced healthcare facilities and demand for less invasive diagnostic tools for cancer screening are driving the growth of the market..
Germany Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (US$ Thousand)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC – MARKET SEGMENTATION
By Application
- Diagnostic
- Therapeutic
By Product
- Instruments
- Reagents
- Software
By End User
- Cancer Institutes
- Hospitals
- Diagnostic Centers
- Others
By Country
- Germany
- France
- UK
- Italy
- Spain
Company Profiles
- Cell Guidance Systems
- Evomic Science LLC
- EXOSOME DIAGNOSTICS
- ITH, Immune Therapy Holdings AB
- Miltenyi Biotec
- Norgen Biotek Corp
- RENEURON GROUP PLC
Europe Exosome Diagnostic and Therapeutic Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 12,524.24 thousand |
| Market Size by 2027 | US$ 1,04,694.72 thousand |
| Global CAGR (2020 - 2027) | 31.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Application
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Application, Product, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
Trends and growth analysis reports related to Life Sciences : READ MORE..
- Cell Guidance Systems
- Evomic Science LLC
- Exosome Diagnostics
- ITH, Immune Therapy Holdings AB
- Miltenyi Biotec
- Norgen Biotek Corp
- Reneuron Group Plc
Get Free Sample For